Skip to content

Psoriasis affects 1-2 of the population

Plaque psoriasis accounts for 90 of all people with psoriasis. The disease more commonly affects the face in children than it does with adults. Population based cohort study and nested cross sectional study. With this in mind, many psoriasis patients can be on multi-drug regimens; Drugs have several ways in which they can affect the diathesis of psoriasis including 1) precipitation of psoriasis de novo in predisposed and nonpredisposed individuals; 2) exacerbation of pre-existing psoriatic lesions; 3) induction of lesions in clinically normal skin in patients with psoriasis; and 4) development of treatment-resistant psoriasis. Brauchli YB, Jick SS, Meier C. Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study. 2009;181:12.

Psoriasis affects 1-2 of the population 2Sarah Dubois Declercq 1, 2 and Roxane Pouliot 1, 2,. Psoriasis is a serious skin disease that affects a person’s daily life on many levels including professional and social life. The patient then takes one or two powerful body-wide drugs for 1 – 2 years and stops. Psoriasis affects between 1 and 2 percent of the United States population, or about 5.5 million people. Although the disease occurs in all age groups and about equally in men and women, it primarily affects adults. This is sometimes called the 1-2-3 approach.

Participants Cohort study: patients with psoriasis aged 18-90 each matched to up to five patients without psoriasis based on age, practice, and time of visit. Learn more about psoriatic arthritis symptoms, diet, diagnosis, treatment, drugs, and prognosis. Psoriasis, which affects at least four million Americans, is slightly more common in women than in men. At least 50 of every 100 people who have any form of psoriasis have scalp psoriasis.

Promising New Treatments For Psoriasis

Psoriasis affects 1-2 of the population 3Although the skin disease psoriasis was first recognized as a distinct disease as early as 1808 (1), its pathogenic mechanisms have eluded investigators for decades. The patient then takes one or two powerful body-wide drugs for 1 – 2 years and stops.

Risk Of Moderate To Advanced Kidney Disease In Patients With Psoriasis: Population Based Cohort Study